SCHEMBL17367114

SCHEMBL17367114

c1ccc(-n2c3ccccc3c3c4ccc5c6ccccc6n(-c6ccc7cc(-c8ccc9ccccc9c8)ccc7c6)c5c4sc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
S1PR4 O95977 3/20 0.33
S1PR5 Q9H228 3/20 0.33
HPGD P15428 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32
TUBA1A Q71U36 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367107 0.95 KDM4E (0.41) KDM4EATML3MBTL1HPGDPMM2
SCHEMBL17367111 0.91 S1PR5 (0.36) KDM4EATML3MBTL1S1PR4S1PR5
SCHEMBL17367077 0.90 KDM4E (0.40) KDM4EATML3MBTL1S1PR4S1PR5
SCHEMBL19342642 0.86 KDM4E (0.47) KDM4EATML3MBTL1HPGDPIK3CD
SCHEMBL17367110 0.85 L3MBTL1 (0.41) KDM4EATML3MBTL1
SCHEMBL17367027 0.85 KDM4E (0.44) KDM4EATML3MBTL1HPGDPMM2
SCHEMBL17367129 0.84 L3MBTL1 (0.52) KDM4EATML3MBTL1
SCHEMBL17366940 0.83 KDM4E (0.33) KDM4EATML3MBTL1HPGDPIK3CD
SCHEMBL17367122 0.82 KDM4E (0.41) KDM4EATML3MBTL1HPGDPMM2
SCHEMBL17367158 0.82 L3MBTL1 (0.38) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 KDM4E 3404/4885ATM 3202/4885L3MBTL1 717/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 KDM4E 3404/4885ATM 3202/4885L3MBTL1 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.